Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-001280

President and CEO acquired 559,640 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2025-12-31 Grant or award +232,640 2,919,238 D: show line 1 in the form
KIDRON NADAV President and CEO 2025-12-31 Grant or award +327,000 3,246,238 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KIDRON NADAV President and CEO 2025-12-31 Grant or award · Performance Stock Units +109,000 109,000 D: show line 3 in the form
Loading xslF345X05/ownership.xml…